Octopus AIM VCTs portfolio company story: Diaceutics
Providing data analytics and implementation services that enables the advancement of genetic analysis.
What Diaceutics does
Diaceutics provides the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics.
Over the past two years the company have worked consistently with 21 of the global top 30 pharma companies on all major precision medicine drug launches.
Through helping the world’s largest pharma companies commercialise their precision medicines, this enhances their return on investment and improves patients’ lives.
The company generates insights from its aggregated testing data from its worldwide laboratory network. This provides real world evidence that informs the decision making of pharmaceutical companies across hundreds of precision medicine projects.
First investment
March 2019
Sector
Pharmaceuticals and biotechnology
Based in
Belfast, Northern Ireland
What our fund managers say
“We have been investors in Diaceutics since its initial public offering (IPO) and are impressed with the progress it’s made since then. We believe Diaceutics is having a real world impact in finding the right treatments for the right patient”
– Dominic Weller, Senior Fund Manager
Octopus AIM VCTs risks
Company examples are for illustrative purposes only and should not be considered an investment recommendation.
Please remember that the value of an investment in the Octopus AIM VCTs, and any income from it, can fall as well as rise. Investors may not get back the full amount they invest.
Tax treatment depends on individual circumstances and may change in the future. Tax reliefs depend on the VCT maintaining its qualifying status.
VCT shares could fall or rise in value more than shares listed on the main market of the London Stock Exchange. They may also be harder to sell.
Investors should only subscribe for shares on the basis of information contained in the prospectus and Key Information Documents (KIDs), available on the AIM VCTs product page.
More companies we’ve backed
We’re here to support you
Got a question?